Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$179

Avg closing price
Price range

10 Jim Simons Reata Pharmaceuticals Trades

The first Reata Pharmaceuticals trade was made in Q1 2017. Since then Jim Simons bought shares five more times and sold shares on four occasions. The investor sold all their shares in Q3 2020 and doesn't own any shares in Reata Pharmaceuticals anymore.

Avg closing price
Price range
Sold -135 Thousand shares Q3 2020
Avg closing price $124.95
Price range $93.53 - $163.34
Increased shares by 28.2% (+29.6 Thousand shares) Q2 2020
Avg closing price $152.02
Price range $126.30 - $176.56
Sold 56.6% shares (-137 Thousand shares) Q1 2020
Avg closing price $193.06
Price range $124.16 - $247.74
New holding (+242 Thousand shares) Q4 2019
Avg closing price $182.82
Price range $74.57 - $217.92
Sold -99.3 Thousand shares Q1 2019
Avg closing price $83.01
Price range $51.90 - $101.79
Increased shares by 409.2% (+79.8 Thousand shares) Q4 2018
Avg closing price $61.05
Price range $48.76 - $76.44
New holding (+19.5 Thousand shares) Q3 2018
Avg closing price $70.47
Price range $35.64 - $92.06
Sold -35.2 Thousand shares Q3 2017
Avg closing price $30.07
Price range $26.29 - $35.47
Increased shares by 42.7% (+10.5 Thousand shares) Q2 2017
Avg closing price $24.59
Price range $20.01 - $32.25
New holding (+24.7 Thousand shares) Q1 2017
Avg closing price $24.70
Price range $21.67 - $28.89

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!